Clinical trials: Activity Choices, open to volunteers
Lifestyle, Healthy, Pregnancy Related
A Nutrition and Exercise Lifestyle Intervention Program Participant Choice Approach
Interventions that target excessive gestational weight gain (EGWG) with nutrition and exercise behavior change struggle with low program adherence.
- Conditions
- Lifestyle, Healthy, Pregnancy Related, Adherence, Treatment, Nutrition, Healthy
- Trial name
- NELIP (NCT06187675)
- Testing
- Nutrition and Exercise Lifestyle Intervention Program
- Where
- Canada
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Western University, Canada
Healthy Subjects, Behavior, Health
Switching Mediterranean Consumers to Mediterranean Sustainable Healthy Dietary Patterns
The population from Mediterranean countries is abandoning the Mediterranean diet (MD) traditional dietary and lifestyle pattern moving to unhealthier habits because of profound cultural and socio-economic driven lifestyle…
- Conditions
- Healthy Subjects, Behavior, Health, Family
- Trial name
- NCT06057324
- Testing
- AI-based Apps, Mediterranean-based diet toolkit and activities, Healthy plant-based snacks
- Where
- Spain
- Volunteers
- 480 people, healthy volunteers welcome
- Sponsor
- Fundació Eurecat
Problem Behavior, Aggression
Extensions of Resurgence as Choice
Although behavioral treatments for decreasing destructive behavior, such as differential reinforcement of alternative behavior (DRA), are effective in the clinic, problem behavior often returns when a caregiver does not give the…
- Conditions
- Problem Behavior, Aggression, Self-Injury
- Trial name
- NCT05537610
- Testing
- CDT, Control
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Rutgers, The State University of New Jersey
Type2 Diabetes, Life Style
STOP DIABETES - Knowledge-based Solutions
The aim of the Stop Diabetes - Knowledge based solutions (StopDia) consortium project (University of Eastern Finland, National Institute for Health and Welfare, and Technical Research Centre of Finland) is to develop and test…
- Conditions
- Type2 Diabetes, Life Style, Diet Habit, Physical Activity
- Trial name
- StopDia (NCT03156478)
- Testing
- Digital lifestyle intervention group, Combined digital and face-to-face lifestyle intervention group
- Where
- Finland
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- University of Eastern Finland
Physical Activity, Energy Intake
Effects of Acute Sleep Deprivation on Human Behaviours
This study will investigate whether acute sleep deprivation affects appetite, eating behavior, and physical activity in both regular exercisers and physically inactive individuals.
- Conditions
- Physical Activity, Energy Intake, Appetite, Food Choice
- Trial name
- NCT07393607
- Testing
- Normal sleep, Partial sleep deprivation
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- National Taiwan Normal University
Hepatocellular Carcinoma, Cirrhosis
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening…
- Trial name
- NCT06624189
- Testing
- Auto-pended bot liver ultrasound order
- Where
- United States
- Volunteers
- 1,300 people
- Sponsor
- NYU Langone Health
Breast Cancer
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
This study is a randomized controlled, open-label, multicenter phase III clinical study evaluating the efficacy and safety of chemotherapy selected by investigator JSKN003 s in subjects with recurrent or metastatic breast cancer…
- Trial name
- NCT06079983
- Testing
- JSKN003, Capecitabine tablets, Gemcitabine hydrochloride for injection
- Where
- 87 sites in China
- Volunteers
- 400 people
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
HER2 IHC3+ Advanced Colorectal Cancer
A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs
This is a Phase III, randomized, open-label, active-controlled, multicenter study designed to evaluate the efficacy and safety of Injection TQB2102 compared with investigator's choice of treatment in subjects with Human Epidermal…
- Trial name
- NCT07483684
- Testing
- TQB2102 Injection, Trifluridine /Tipiracil (TAS-102) tablets / Fruquintinib / Regorafenib tablets
- Where
- 48 sites in China
- Volunteers
- 142 people
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.